HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shuichiro Sakamoto Selected Research

1- (3',4'- dihydroxybenzyl)- 1,2,3,4- tetrahydroisoquinoline

9/2014Endogenous neurotoxic dopamine derivative covalently binds to Parkinson's disease-associated ubiquitin C-terminal hydrolase L1 and alters its structure and function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shuichiro Sakamoto Research Topics

Disease

1Starvation
01/2017
1Parkinson Disease (Parkinson's Disease)
09/2014
1Parkinsonian Disorders (Parkinsonism)
09/2014

Drug/Important Bio-Agent (IBA)

1Glucose (Dextrose)FDA LinkGeneric
01/2017
1Dopamine (Intropin)FDA LinkGeneric
09/2014
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
09/2014
1catechol (pyrocatechol)IBA
09/2014
1Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA
09/2014
11- (3',4'- dihydroxybenzyl)- 1,2,3,4- tetrahydroisoquinolineIBA
09/2014